Provided by Tiger Trade Technology Pte. Ltd.

BEONE MEDICINES

207.000
-1.600-0.77%
Volume:3.78M
Turnover:782.72M
Market Cap:319.19B
PE:138.93
High:211.200
Open:209.800
Low:206.000
Close:208.600
52wk High:235.600
52wk Low:153.000
Shares:1.54B
HK Float Shares:1.43B
Volume Ratio:1.10
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.490
ROE:14.66%
ROA:7.46%
PB:7.87
PE(LYR):138.93
PS:6.64

Loading ...

BeiGene Q2 Adj. EPS $3.84 Beats $1.44 Estimate, Sales $1.705B Beat $1.591B Estimate

Benzinga Earnings
·
Aug 05

Movement Alert|BEONE MEDICINES Rises 3.05% in Regular Trading, Q2 Earnings Release Coupled with Innovative Drug Sector Momentum

Market Focus
·
Aug 05

BeOne Medicines Updates Articles of Association: Sets USD0.15 Bn Share Capital, Introduces Capital Band and Conditional Share Pools

Bulletin Express
·
Aug 05

BeOne Medicines boosts HK share capital by 0.06% via 866,073-share issuance for employee plan

Bulletin Express
·
Aug 05

BeOne Medicines AG Expected to Post Earnings of 15 Cents a Share - Earnings Preview

Reuters
·
Aug 03

China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Stock News
·
Jul 31

Beigene Issues 866,100 New Shares Under Employee Stock Purchase Plan

Stock News
·
Jul 30

Earning Preview: BEIGENE Q2 revenue is expected to increase by 0% to 1.59 billion, institutions lean bullish

Earnings Agent
·
Jul 29

Movement Alert|BEIGENE Rises 3.33% in Regular Trading, Nomura Raises Target Price to HK$270.74 Boosting Sentiment

Market Focus
·
Jul 29

Movement Alert|BEIGENE Falls 3.15% in Regular Trading, Biotech Sector Retreats After Strong Monthly Rally

Market Focus
·
Jul 28

Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks

Stock News
·
Jul 24

BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market

Deep News
·
Jul 24

Movement Alert|BEIGENE Rises 4.13% in Regular Trading, Adds $300 Million Investment to Expand US Manufacturing

Market Focus
·
Jul 24

Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial

Deep News
·
Jul 23

Movement Alert|BeOne Medicines Rises 3.39% in Regular Trading, Trading at HK$192.7

Market Focus
·
Jul 20

Movement Alert|BeiGene Falls 3.04% in Regular Trading, Trading at HKD 185.5

Market Focus
·
Jul 17

Movement Alert|BeOne Medicines Rises 3.23% in Regular Trading, Biotech Sector Rallies on Policy Tailwinds from National Essential Drug List Update

Market Focus
·
Jul 15

Movement Alert|BeOne Medicines Rises 3.19% in Regular Trading, Brukinsa MANGROVE Phase 3 Data and New Buy Rating Drive Momentum

Market Focus
·
Jul 10

BeiGene grants 33,388 ADS-linked RSUs to 215 employees, equal to 0.03% of share capital

Bulletin Express
·
Jul 08

BEIGENE Awards Aggregate 33,400 Restricted Stock Units Represented by American Depositary Shares

Stock News
·
Jul 08